Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADK | P55263 | 16/20 | 0.83 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.75 |
| ▸ | DOT1L | Q8TEK3 | 3/20 | 0.71 |
| ▸ | NPC1 | O15118 | 1/20 | 0.71 |
| ▸ | GALR3 | O60755 | 1/20 | 0.71 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.71 |
| ▸ | MAPT | P10636 | 1/20 | 0.71 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.71 |
| ▸ | HTT | P42858 | 1/20 | 0.71 |
| ▸ | RAB9A | P51151 | 1/20 | 0.71 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.71 |
| ▸ | HASPIN | Q8TF76 | 1/20 | 0.67 |
| ▸ | DCLK1 | O15075 | 1/20 | 0.65 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.65 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.65 |
| ▸ | CDK1 | P06493 | 1/20 | 0.65 |
| ▸ | ROS1 | P08922 | 1/20 | 0.65 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.65 |
| ▸ | CDK2 | P24941 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodotubercidin SCHEMBL12618424 | 1.00 | ADK (0.83) | ADKSLC29A1DOT1LNPC1GALR3 | |
| Iodotubercidin SCHEMBL2786488 | 1.00 | ADK (0.83) | ADKSLC29A1DOT1LNPC1GALR3 | |
| Iodotubercidin SCHEMBL12505209 | 1.00 | ADK (0.83) | ADKSLC29A1DOT1LNPC1GALR3 | |
| Iodotubercidin SCHEMBL29383008 | 1.00 | ADK (0.83) | ADKSLC29A1DOT1LNPC1GALR3 | |
| Iodotubercidin SCHEMBL319225 | 1.00 | ADK (0.83) | ADKSLC29A1DOT1LNPC1GALR3 | |
| Iodotubercidin SCHEMBL13021361 | 1.00 | ADK (0.83) | ADKSLC29A1DOT1LNPC1GALR3 | |
| Iodotubercidin SCHEMBL12652819 | 1.00 | ADK (0.83) | ADKSLC29A1DOT1LNPC1GALR3 | |
| Iodotubercidin SCHEMBL8328935 | 1.00 | ADK (0.83) | ADKSLC29A1DOT1LNPC1GALR3 | |
| Iodotubercidin SCHEMBL16978206 | 1.00 | ADK (0.83) | ADKSLC29A1DOT1LNPC1GALR3 | |
| Iodotubercidin SCHEMBL2043545 | 1.00 | ADK (0.83) | ADKSLC29A1DOT1LNPC1GALR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4602148-A1 | METHODS FOR CHEMICAL REPROGRAMMING AND PLURIPOTENT STEM CELLS | Peking University (CN) | 2025-08-20 | — | — | EP | claimed |
| WO-2024078119-A1 | METHODS FOR CHEMICAL REPROGRAMMING AND PLURIPOTENT STEM CELLS | PEKING UNIVERSITY (CN) | 2024-04-18 | — | — | WO | claimed |
| WO-2023059810-A1 | STENTS AND METHODS OF USE | UNIVERSITY OF CONNECTICUT (US) | 2023-04-13 | — | — | WO | claimed |
| WO-2023044463-A1 | SILK FIBROIN DERIVED BRUSH-LIKE POLYMERS | UNIVERSITY OF CONNECTICUT (US) | 2023-03-23 | — | — | WO | claimed |
| WO-2023039578-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER | OMEROS CORPORATION (US) | 2023-03-16 | — | — | WO | claimed |
| CN-122055439-A | Methods for differentiating dopaminergic neurons from stem cells | 艾斯本神经科学公司 | 2026-05-15 | — | — | CN | disclosed |
| EP-3129065-B1 | TARGETED DRUG DELIVERY THROUGH AFFINITY BASED LINKERS | AKAMARA THERAPEUTICS INC (US) | 2026-05-13 | — | — | EP | disclosed |
| US-20260124324-A1 | PHOTOCLICK CHEMISTRY OF SILK FOR TEMPORARY UV TATTOOS | TUFTS COLLEGE (US) | 2026-05-07 | — | — | US | disclosed |
| EP-4734896-A2 | BIOPOLYMER-BASED TYMPANOSTOMY TUBES WITH PROGRAMMABLE, TUNABLE, AND ON-DEMAND DEGRADATION | Trustees Of Tufts College (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-4735018-A2 | CENTRIFUGALLY-MOLDED ARTICLES AND METHODS | Trustees Of Tufts College (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-4728055-A2 | METHODS FOR DIFFERENTIATING DOPAMINERGIC NEURONS FROM STEM CELLS | Aspen Neuroscience, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-12590294-B2 | Process for producing cardiomyocytes | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2026-03-31 | — | — | US | disclosed |
| US-20220175738-A1 | Tip60 Inhibitors and Methods of Use for Cardiovascular Disease | THE MEDICAL COLLEGE OF WISCONSIN, INC. | 2022-06-09 | — | — | US | disclosed |
| WO-2022098880-A1 | TOPICAL FORMULATION COMPRISING OMEGA-3 FATTY ACIDS, MELATONIN AND VITAMIN D | AMBO INNOVATIONS LLC (US) | 2022-05-12 | — | — | WO | disclosed |
| WO-2022098992-A1 | USE OF MACROCYCLIC COMPOUNDS IN METHODS OF TREATING CANCER | SCORPION THERAPEUTICS, INC. (US) | 2022-05-12 | — | — | WO | disclosed |
| US-11318230-B2 | Platelet-derived growth factor compositions and methods of use thereof | BIOMIMETIC THERAPEUTICS, LLC (US) | 2022-05-03 | — | — | US | disclosed |
| US-20220072204-A1 | Platelet-Derived Growth Factor Compositions and Methods of Use Thereof | BIOMIMETIC THERAPEUTICS LLC (US) | 2022-03-10 | — | — | US | disclosed |
| WO-2022040566-A1 | METHODS AND USES OF HALOFUGINONE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-02-24 | — | — | WO | disclosed |
| US-11247181-B2 | Biomimetic multilayer compositions | TRUSTEES OF TUFTS COLLEGE (US) | 2022-02-15 | — | — | US | disclosed |
| EP-3947463-A1 | TREATMENT OF CANCER UTILIZING AN IDENTIFIED ADENOSINE FINGERPRINT | Arcus Biosciences, Inc. (US) | 2022-02-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260124324-A1 | PHOTOCLICK CHEMISTRY OF SILK FOR TEMPORARY UV TATTOOS | PTMS, ITK, MATK | ADK 931/4885SLC29A1 4565/4885DOT1L 1384/4885 |
| US-12590294-B2 | Process for producing cardiomyocytes | RARB, RARA, FABP3 | ADK 1802/4885SLC29A1 3917/4885DOT1L 4567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.